首页> 外文期刊>Geriatrics & gerontology international. >Glycemic control and disability‐free survival in hypoglycemic agent‐treated community‐dwelling older patients with type 2 diabetes mellitus
【24h】

Glycemic control and disability‐free survival in hypoglycemic agent‐treated community‐dwelling older patients with type 2 diabetes mellitus

机译:降血糖药物治疗的患有2型糖尿病患者的血糖控制和无残疾生存

获取原文
获取原文并翻译 | 示例
           

摘要

Aim Although lower glycated hemoglobin (HbA 1c ) has been believed to be an important marker of improvement of glycemic control in order to maintain better quality of life for patients with diabetes mellitus, a too low HbA 1c might be harmful in older adults. We investigated whether this was the case with respect to risk of support/care‐need certification in community‐dwelling older patients with type 2 diabetes mellitus. Methods We analyzed 184 diabetes patients aged 65–94 years receiving glucose‐lowering medication/insulin. The end‐points were first support/care‐need certification and/or death. The relationships between four classes of HbA 1c and risk of support/care‐need certification and/or death were determined using the Cox proportional hazards regression model. Results During 5 years, 42 first support/care‐need certifications and 13 deaths occurred. The association of HbA 1c with risk of support/care‐need certification after adjustment for age, sex and confounding variables was J‐shaped, with the nadir at an HbA 1c level of 6.5 to 7.0%, and with an increased risk of support/care‐need certification (HR 3.45, 95% CI 1.02–11.6, P = 0.046) at an HbA 1c level of 6.0% compared with the nadir. When compared with patients with HbA 1c ≥6.0%, those with HbA 1c 6.0% showed a higher risk of support/care‐need certification as a result of dementia (HR 12.5, 95% CI 3.00–52.2, P = 0.001), but not as a result of arthralgia/fracture, stroke or other disorders. Conclusions These observations show that a too low HbA 1c might be associated with a later risk of incident disability as a result of dementia in community‐dwelling older diabetes patients. Geriatr Gerontol Int 2017; 17: 1858–1865 .
机译:旨在降低糖化血红蛋白(HBA 1C)的血液血红蛋白(HBA 1C)是改善血糖控制的重要标记,以便为糖尿病患者保持更好的生活质量,但HBA 1C的患者可能对老年人有害。我们调查了这是否是关于患有2型糖尿病2型糖尿病患者的支持/护理需要认证的风险。方法分析了184名糖尿病患者65-94岁,接受葡萄糖降低药物/胰岛素。最终点是首先支持/护理需要认证和/或死亡。使用Cox比例危害回归模型确定四类HBA 1C类别和支持/护理需要认证和/或死亡风险的关系。结果5年来,第42名首次支持/护理需要认证和13人死亡。 HBA 1C的关联在调整年龄,性和混淆变量后的支持/护理需要认证的风险是J形,Nadir在HBA 1C水平为6.5至7.0%,并且风险增加与Nadir相比,支持/护理需要认证(HR 3.45,95%CI 1.02-11.6,P = 0.046)。与HBA1C≥6.0%的患者相比,具有HBA 1C的患者。由于痴呆症(HR 12.5,95%CI 3.00-52.2,P = 0.001)显示出较高的支持/护理需要认证的风险更高,但不是关节痛/骨折,中风或其他疾病的结果。结论这些观察结果表明,由于社区住宅较旧糖尿病患者的痴呆症,过低的HBA 1C可能与发生的事件残疾的风险有关。 Geriadt Gerontol int 2017; 17:1858-1865。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号